You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨康寧傑瑞逆勢升超8%,將在SITC年會公佈研究成果
康寧傑瑞製藥-B(9966.HK)今日盤中逆勢升超8%,報4.47港元。消息面上,集團公佈,自主研發用於治療HER2表達晚期或轉移性實體瘤的JSKN033I/II期臨牀試驗,相關最新研究成果,獲入選2024年癌症免疫治療學會(SITC)年會最新突破性摘要,且於年會期間以壁報形式首次公佈。JSKN033-101是一項開放、多中心及首次人體的I/II期臨牀試驗,旨在評估JSKN033在晚期HER2表達實體瘤(IHC≥1+)或HER2突變非小細胞肺癌患者中的安全性、耐受性和初步有效性。(格隆匯)

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account